Official UK procurement notice
Covid-19: DHSC: NHSX - Remote Symptoms Tracking System, App and supply of SpO2 Devices
Authority: Department of Health & Social Care (Central government)
What is being bought
Published requirement descriptionThis procurement was awarded in April 2020 for access to the "Medopad software as a service and Application" for a pilot in two London NHS Trusts.The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20/04/20 to 31/12/20 inclusive. However, DHSC had to purchase 20,000 Pulse Oximeters at pace to allocate to the Pilot's patients, and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification.
CPV: Medical software package · Patient-monitoring system
The lotProcurement structure
single lot · no lot value publishedLot #1A programme to deploy remote monitoring of COVID patientsNHSX was reviewing the…Awarded
A programme to deploy remote monitoring of COVID patientsNHSX was reviewing the deployment of remote monitoring to ensure that patients have access to medical care during the Covid19 pandemic. Medopad (owned by Huma Therapeutics Ltd) is a remote monitoring product that had completed the Digital Health London accelerator, and had approached NHSX (following the national call for innovator assistance) following their similar work with other EU governments, as part of their Covid19 response. The two use cases is for this programme of work were to perform daily monitoring on the Covid-19 patients that had been recently discharged from hospital and provide an electronic monitoring of potential Covid-19 patients who were routed through primary care hot hubs. Both use cases allowed the early identification of deterioration of patients and ensure that health professionals could intervene before their patients found it difficult to breath and had long lasting damage to their lungs. This procurement was for access to the "Medopad software as a service and Application" for a pilot in two London NHS Trusts.The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20/04/20 to 31/12/20 inclusive. However, DHSC had to purchase 20,000 Pulse Oximeters at pace to allocate to the Pilot's patients and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification.. Additional information: A copy of the redacted contract is provided at the following linkatamis-1928.cloudforce.com/sfc/p/0O000000rwim/a… ↗
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 6 Mar 2021, 10:17 GMT
- Last source update
- 6 Mar 2021, 10:17 GMT
- Authority reference
C25022- FTS notice number
2021/S 000-004532- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-029925Find a Tender
- Why no open competition
The products involved are manufactured purely for the purpose of research, experiment, study or development under the conditions stated in the directive; Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive
- Published justification
The Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 Mar 2020.COVID-19 is serious and its consequences pose a risk to life. Cabinet Office published PPN 01/20: Responding to COVID-19 on procuring with extreme urgency in March 2020 which states that contracting authorities may enter into contracts withoutcompeting or advertising the requirement where certain tests are met.1) There are genuine reasons for extreme urgency as there is a significant public health risk requiring immediate action as a result of COVID-19 2) The COVID-19 situation is novel and the Contracting Authority could not have reasonably foreseen these events3) It is not possible to comply with the timescales of another procedure due to the urgent requirement to obtain the [supplies] being contracted for. Additionally, there are many buyers competing for the same supplies. It is imperative that security of supply is maintained. Demand for equipment is high and there is little or no incentive for suppliers to participate in competitive procurement procedures. 4) The situation is not attributable to the contracting authority]This procurement was awarded in April 2020 for access to the "Medopad software as a service and Application" for a pilot in two London NHS Trusts. The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20/04/20 to 31/12/20 inclusive. However, DHSC had to purchase 20,000 Pulse Oximeters at pace to allocate to the Pilot's patients, and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification.
Publisher note: A copy of the redacted contract is provided at the following linkhttps://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kHb2/6dYIxgutqoH6wT7FRGhuKv.vO33BHUY6PZLTFcQmoqA
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Huma Therapeutics Limited | £282,218 † | — | Awarded |
Contracts
Contract 004532-2021-1 · Huma Therapeutics Limited
- Signed
- 17 Apr 2020
- Value
- £282,218
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High CourtMediation bodyReview body
Bidders & participating suppliers
1 commercial party on the notice- Huma Therapeutics LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.